ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
201 | 63.69299 | 1 | female | 0 | 9 | 117 | CHF | COPD/CHF/Cirrhosis | 3 | 11 | $11-$25k | 0 | 46,112 | 24,669.1562 | null | 25.5 | white | 27 | 40 | 0.746948 | 0.601929 | 3 | 1 | 0 | no | null | null | dnr after sadm | 3 | 52 | 10.699219 | 122 | 32 | 39.09375 | null | null | null | 0.899902 | 134 | null | null | null | null | 3 | 3 | SIP>=30 | 3 |
202 | 62.185 | 1 | female | 0 | 18 | 1,780 | Lung Cancer | Cancer | 1 | null | null | 0 | 35,575 | 23,257.5938 | null | 9 | black | 4 | 9 | 0.889893 | 0.748901 | 1 | 0 | 0 | metastatic | 0.8 | 0.7 | no dnr | 18 | 86 | 7.699219 | 60 | 18 | 37.19531 | null | 4.399414 | 0.199982 | 0.899902 | 140 | null | null | null | null | null | null | null | 2.390625 |
203 | 53.52197 | 0 | female | 0 | 9 | 1,874 | COPD | COPD/CHF/Cirrhosis | 3 | 12 | $11-$25k | 9 | 20,893 | 12,010.2578 | null | 10.5 | white | 24 | 36 | 0.846924 | 0.747925 | 2 | 0 | 0 | no | 0.9 | 0.7 | no dnr | 9 | 92 | null | 112 | 36 | 37.5 | 174.96875 | 3.299805 | 0.299988 | 0.699951 | 139 | 7.369141 | null | null | null | null | null | no(M2 and SIP pres) | 4.283203 |
204 | 23.39999 | 1 | female | 1 | 96 | 96 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 11 | $11-$25k | 26 | 943,804 | 473,212.25 | null | 28.5 | hispanic | 30 | 42 | 0.719971 | 0.633911 | 36 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 96 | 87 | 5.199219 | 144 | 45 | 37.29688 | 335 | 3 | 4.099609 | 1.199951 | 130 | 7.469727 | null | null | null | null | 0 | Coma or Intub | 0 |
205 | 65.60999 | 1 | female | 0 | 7 | 279 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | null | 0 | 25,467 | 13,346.1172 | null | 11.5 | white | 34.796875 | 38 | 0.562988 | 0.367981 | 3 | 0 | 0 | no | null | null | no dnr | 7 | 94 | 7.399414 | 140 | 24 | 35.79688 | 390.4375 | null | null | 2.699707 | 122 | 7.479492 | null | null | null | 0 | 2 | SIP>=30 | 2 |
206 | 70.28094 | 1 | male | 1 | 14 | 14 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | null | null | 0 | 28,159 | 15,654.1641 | null | 9.666664 | white | 27.398438 | 40 | 0.557983 | 0.362 | 1 | 0 | 0 | no | 1 | 1 | no dnr | 14 | 106 | 10.398438 | 74 | 20 | 37 | null | 3.099609 | 4.699219 | 3 | 129 | null | null | null | null | 1 | null | <2 mo. follow-up | 1.1669 |
207 | 60.71997 | 1 | male | 1 | 4 | 4 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 0 | 63,858 | 32,674.75 | null | 48 | white | 39 | 53 | 0.317993 | 0.203979 | 12 | 0 | 0 | yes | null | null | dnr after sadm | 4 | 47 | 14.798828 | 80 | 14 | 35.79688 | 135 | 2.599609 | 1.899902 | 4 | 138 | 7.30957 | null | null | null | null | null | <2 mo. follow-up | 2.666504 |
208 | 77.00494 | 1 | female | 0 | 11 | 40 | CHF | COPD/CHF/Cirrhosis | 2 | null | null | 0 | 15,565 | 10,120.9297 | null | 8 | white | 13.898438 | 20 | 0.888916 | 0.813965 | 1 | 1 | 0 | no | 0.5 | 0.25 | no dnr | 11 | 99 | 8.599609 | 80 | 24 | 36.5 | null | null | null | 1 | 138 | null | null | null | null | null | null | <2 mo. follow-up | 3.014648 |
209 | 42.05298 | 1 | male | 0 | 9 | 149 | CHF | COPD/CHF/Cirrhosis | 1 | 12 | $11-$25k | 0 | 24,897 | 14,291.5391 | null | 15 | hispanic | 13.798828 | 22 | 0.946899 | 0.909912 | 1 | 0 | 0 | no | 0.8 | 0.5 | no dnr | 9 | 62 | 10.099609 | 120 | 24 | 36.79688 | null | 4.5 | 1 | 1.299805 | 140 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
210 | 60.75 | 1 | female | 1 | 6 | 6 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 254,366 | 144,957.75 | null | 47 | asian | 40.59375 | 71 | 0.369995 | 0.251953 | 9 | 0 | 0 | no | null | null | dnr after sadm | 6 | 63 | 17.5 | 150 | 32 | 38.69531 | 89 | 2.899902 | 7.099609 | 2.299805 | 139 | 7.30957 | null | null | null | null | null | <2 mo. follow-up | 2.524902 |
211 | 71.28796 | 1 | male | 1 | 5 | 5 | CHF | COPD/CHF/Cirrhosis | 1 | 15 | null | 0 | 4,854 | 3,407.7559 | null | 6 | white | 23.5 | 36 | 0.795898 | 0.671997 | 1 | 0 | 0 | no | null | null | dnr after sadm | 1 | 63 | 7.299805 | 82 | 12 | 36.19531 | null | null | null | 1.699951 | 127 | null | null | null | null | null | 0 | <2 mo. follow-up | 0 |
212 | 22.66899 | 1 | female | 0 | 9 | 101 | CHF | COPD/CHF/Cirrhosis | 1 | 15 | null | 0 | 18,751 | 10,188.0078 | null | 16 | hispanic | 51.695313 | 47 | 0.464966 | 0.262939 | 1 | 0 | 0 | no | 0.6 | 0.2 | no dnr | 9 | 35 | 6.699219 | 115 | 40 | 36.39844 | 175.5 | null | null | 1.299805 | 117 | 7.5 | null | null | null | 4 | null | adl>=4 (>=5 if sur) | 3.183199 |
213 | 59.12399 | 0 | female | 0 | 9 | 1,867 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 11 | $11-$25k | 0 | 43,164 | 22,028.3438 | null | 24 | white | 27.699219 | 56 | 0.756958 | 0.679932 | 2 | 1 | 0 | no | null | null | no dnr | 9 | 57 | 17.699219 | 156 | 14 | 37.5 | 170 | 3.099609 | 1.299805 | 1.5 | 140 | 7.299805 | null | null | null | null | 7 | null | 7 |
214 | 63.896 | 0 | male | 0 | 55 | 1,867 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 12 | >$50k | 0 | 227,392 | 139,701.25 | null | 21.5 | hispanic | 21.898438 | 45 | 0.734985 | 0.584961 | 1 | 0 | 0 | no | null | null | no dnr | 55 | 72 | 8.599609 | 105 | 18 | 38.39844 | 338.0625 | 2.399902 | 9 | 1 | 135 | 7.469727 | null | null | null | 3 | 5 | SIP>=30 | 5 |
215 | 87.43097 | 1 | male | 1 | 16 | 16 | CHF | COPD/CHF/Cirrhosis | 2 | null | null | 0 | 89,889 | 43,052.125 | null | 31.333328 | white | 37.5 | 49 | 0.334961 | 0.148987 | 2 | 0 | 0 | no | null | null | dnr after sadm | 14 | 75 | 13.398438 | 135 | 8 | 37.79688 | 138 | null | null | 3.199707 | 125 | 7.299805 | null | null | null | null | null | <2 mo. follow-up | 3.553711 |
216 | 78.89899 | 0 | male | 0 | 22 | 1,863 | COPD | COPD/CHF/Cirrhosis | 1 | 12 | null | 0 | 40,247 | 22,146.5 | null | 10.333328 | white | 15.5 | 21 | 0.848999 | 0.751953 | 1 | 0 | 0 | no | 0.8 | 0.5 | no dnr | 22 | 94 | 8.798828 | 75 | 26 | 36.5 | 326.0625 | null | null | 0.899902 | 139 | 7.329102 | null | null | null | 2 | 0 | null | 0 |
217 | 83.64099 | 0 | male | 0 | 12 | 1,862 | CHF | COPD/CHF/Cirrhosis | 1 | 10 | null | 9 | 25,653 | 14,852.3984 | null | 14.5 | white | 25.5 | 55 | 0.670898 | 0.498962 | 1 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 12 | 63 | 10.699219 | 62 | 28 | 39.39844 | 214.28125 | null | 1 | 2.5 | 131 | 7.439453 | null | null | null | 1 | 1 | null | 1 |
218 | 47.737 | 0 | female | 0 | 116 | 1,861 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | null | 0 | 592,486 | 298,585.25 | null | 45.5 | black | 50.59375 | 79 | 0.237 | 0.135986 | 2 | 0 | 0 | no | null | null | no dnr | 116 | 47 | 13.099609 | 164 | 31 | 39.29688 | 52 | null | null | 3 | 130 | 7.139648 | null | null | null | null | 1 | Coma or Intub | 1 |
219 | 78.84998 | 0 | female | 0 | 9 | 1,860 | CHF | COPD/CHF/Cirrhosis | 3 | 8 | null | 0 | 9,914 | 6,578.9141 | null | 7 | black | 10.398438 | 38 | 0.910889 | 0.849976 | 1 | 1 | 0 | no | null | null | no dnr | 9 | 114 | 8.398438 | 78 | 20 | 37.79688 | 328.5625 | 3.899902 | 0.799927 | 1.299805 | 137 | 7.459961 | null | null | null | 4 | 6 | SIP>=30 | 6 |
220 | 51.18399 | 0 | male | 0 | 10 | 1,860 | CHF | COPD/CHF/Cirrhosis | 3 | 6 | under $11k | 0 | 22,621 | 13,689.9297 | null | 17.5 | black | 21.296875 | 14 | 0.875977 | 0.793945 | 2 | 0 | 0 | no | 0.8 | 0.6 | no dnr | 10 | 88 | 7 | 80 | 18 | 36.69531 | null | null | 3.5 | 1.099854 | 126 | null | null | null | null | 1 | null | no(M2 and SIP pres) | 1.1669 |
221 | 61.45398 | 1 | male | 0 | 16 | 523 | Colon Cancer | Cancer | 1 | 30 | >$50k | 0 | 60,175 | 33,484.4375 | null | 17.666656 | white | 15.599609 | 24 | 0.840942 | 0.650879 | 1 | 0 | 0 | metastatic | 0.95 | 0.75 | no dnr | 16 | 102 | 12.898438 | 90 | 20 | 37 | null | 3.599609 | 0.5 | 1.5 | 137 | null | null | null | null | null | null | no(M2 and SIP pres) | 2.055664 |
222 | 55.20297 | 1 | male | 0 | 3 | 1,285 | CHF | COPD/CHF/Cirrhosis | 4 | 15 | under $11k | 0 | 3,035 | 2,104.1055 | null | 3 | other | 14.599609 | 16 | 0.924927 | 0.873901 | 1 | 1 | 0 | no | 0.8 | 0.7 | no dnr | 3 | 93 | 11.199219 | 74 | 24 | 36 | null | 3.899902 | 0.699951 | 1.299805 | 136 | null | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
223 | 74.06396 | 0 | male | 0 | 11 | 1,859 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 44,728 | 25,857.0625 | null | 22 | white | 22.796875 | 20 | 0.767944 | 0.69397 | 3 | 0 | 0 | no | null | null | no dnr | 11 | 115 | 10 | 95 | 12 | 37.5 | 113.84375 | null | null | 1.099854 | 135 | 7.449219 | null | null | null | null | null | null | 2.402832 |
224 | 90.90796 | 1 | female | 1 | 17 | 17 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 0 | 69,364 | 35,313.4375 | null | 21.333328 | white | 19 | 24 | 0.790894 | 0.721924 | 1 | 0 | 0 | no | 0.2 | 0.2 | dnr after sadm | 13 | 133 | 16.296875 | 115 | 9 | 38.5 | 372.5 | 2.799805 | null | 1 | 137 | 7.399414 | null | null | null | null | 5 | <2 mo. follow-up | 5 |
225 | 38.94897 | 1 | male | 1 | 24 | 24 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 9 | $11-$25k | 0 | 133,918 | 68,405.4375 | null | 18.333328 | hispanic | 35.695313 | 59 | 0.639893 | 0.458984 | 1 | 0 | 0 | no | 0.75 | 0.5 | dnr after sadm | 23 | 64 | 12.099609 | 102 | 18 | 36.39844 | null | 2 | 10.199219 | 2.799805 | 126 | null | null | null | null | 5 | 3 | <2 mo. follow-up | 3 |
226 | 65.14697 | 1 | female | 0 | 4 | 27 | Lung Cancer | Cancer | 1 | null | null | 0 | 5,223 | 3,330.9004 | null | 7 | white | 19.199219 | 10 | 0.661987 | 0.358948 | 1 | 0 | 0 | metastatic | null | null | no dnr | 4 | 83 | 8.099609 | 106 | 22 | 36.39844 | null | null | null | 0.699951 | 136 | null | null | null | null | null | null | <2 mo. follow-up | 2.418945 |
227 | 51.62799 | 1 | female | 0 | 8 | 557 | CHF | COPD/CHF/Cirrhosis | 3 | 13 | $25-$50k | 0 | 23,146 | 13,344.6172 | null | 16 | white | 18.398438 | 17 | 0.906982 | 0.843994 | 1 | 1 | 0 | no | null | null | no dnr | 8 | 65 | 15.898438 | 88 | 16 | 36.29688 | null | 4.199219 | 1 | 1.099854 | 128 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
228 | 56.20499 | 1 | male | 0 | 20 | 153 | Lung Cancer | Cancer | 2 | null | null | 0 | 42,041 | 27,174.3594 | null | 12 | white | 6.5 | 12 | 0.873901 | 0.715942 | 1 | 0 | 0 | metastatic | null | null | no dnr | 20 | 107 | 8.199219 | 92 | 20 | 37.19531 | 304.75 | 4.199219 | 0.299988 | 0.899902 | 135 | 7.439453 | null | null | null | null | null | no(M2 and SIP pres) | 2.779785 |
229 | 65.88599 | 0 | female | 0 | 5 | 1,857 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 26 | 19,662 | 10,503.0391 | null | 21 | white | 18 | 31 | 0.823975 | 0.763916 | 1 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 5 | 61 | 8.398438 | 60 | 30 | 37 | 217.125 | 1.899902 | 0.699951 | 0.5 | 139 | 7.489258 | null | null | null | null | null | null | 2.237793 |
230 | 69.19598 | 1 | male | 0 | 9 | 115 | CHF | COPD/CHF/Cirrhosis | 2 | 14 | $11-$25k | 0 | 24,859 | 14,226.4688 | null | 20.5 | asian | 32.398438 | 45 | 0.639893 | 0.458984 | 1 | 0 | 0 | no | null | null | no dnr | 9 | 47 | 13.798828 | 70 | 20 | 36.79688 | 565 | 3.699707 | 0.699951 | 2.399902 | 126 | 7.5 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
231 | 77.74695 | 1 | male | 0 | 6 | 422 | Lung Cancer | Cancer | 1 | null | null | 0 | 16,325 | 7,677.7969 | null | 11 | other | 16.796875 | 18 | 0.681885 | 0.386963 | 1 | 0 | 0 | metastatic | null | null | no dnr | 6 | 89 | 19.296875 | 80 | 18 | 36.89844 | null | null | 0.5 | 1.299805 | 133 | null | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
232 | 80.09595 | 1 | male | 0 | 3 | 1,314 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | $11-$25k | 0 | 5,293 | 3,081.8906 | null | 8 | white | 17.097656 | 11 | 0.848999 | 0.750977 | 1 | 0 | 0 | no | null | null | no dnr | 3 | 93 | null | 80 | 20 | 36.79688 | null | null | null | 0.699951 | 131 | null | null | null | null | 5 | 6 | SIP>=30 | 6 |
233 | 71.54596 | 1 | male | 0 | 7 | 77 | Lung Cancer | Cancer | 1 | 20 | >$50k | 0 | 23,304 | 12,482.875 | null | 12 | white | 15.398438 | 26 | 0.692993 | 0.402954 | 3 | 0 | 0 | metastatic | null | null | no dnr | 7 | 120 | 3.5 | 89 | 26 | 36.89844 | 257.125 | null | 0.599976 | 1.199951 | 137 | 7.509766 | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
234 | 60.61899 | 1 | male | 0 | 17 | 236 | CHF | COPD/CHF/Cirrhosis | 1 | 14 | null | 0 | 49,079 | 26,983.6719 | null | 16 | white | 22.796875 | 31 | 0.843994 | 0.743896 | 1 | 0 | 0 | no | 0.95 | 0.9 | no dnr | 17 | 50 | 6.099609 | 110 | 20 | 36.79688 | null | 3.699707 | 0.399963 | 1.199951 | 135 | null | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
235 | 58.478 | 1 | male | 0 | 4 | 896 | CHF | COPD/CHF/Cirrhosis | 4 | null | null | 0 | 3,580 | 1,780.9941 | null | 11 | white | 20.097656 | 36 | 0.87793 | 0.796997 | 1 | 1 | 0 | no | null | null | no dnr | 4 | 106 | 9.099609 | 88 | 36 | 36.39844 | null | null | null | 1.899902 | 139 | null | null | null | null | null | null | null | 2.603027 |
236 | 52.67899 | 0 | male | 0 | 5 | 1,853 | CHF | COPD/CHF/Cirrhosis | 2 | 16 | null | 0 | 17,110 | 10,086.7188 | null | 21 | asian | 15.398438 | 27 | 0.924927 | 0.872925 | 1 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 5 | 60 | 3.599609 | 150 | 16 | 36.79688 | null | 4.099609 | 0.699951 | 1.099854 | 137 | null | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
237 | 70.48596 | 1 | male | 0 | 37 | 336 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 149,983 | 76,851.75 | null | 27.5 | white | 19.199219 | 27 | 0.850952 | 0.799927 | 1 | 0 | 1 | no | null | null | no dnr | 37 | 62 | 14.099609 | 80 | 15 | 38.5 | 146 | 2.399902 | 0.399963 | 1.099854 | 134 | 7.449219 | null | null | null | null | null | null | 3.696777 |
238 | 50.58197 | 1 | male | 0 | 7 | 81 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 10 | $25-$50k | 0 | 9,113 | 5,367.9805 | null | 13 | hispanic | 20 | 38 | 0.837891 | 0.733887 | 1 | 0 | 0 | no | null | null | no dnr | 7 | 70 | 3.599609 | 82 | 20 | 36.79688 | 385.6875 | 1.899902 | 1.799805 | 1.599854 | 128 | 7.489258 | null | null | null | 4 | null | Coma or Intub | 3.183199 |
239 | 25.487 | 1 | male | 1 | 19 | 19 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 126,732 | 61,916.2188 | null | 19.666656 | white | 37.59375 | 61 | 0.682983 | 0.589966 | 1 | 0 | 0 | yes | 0.7 | 0.5 | dnr after sadm | 19 | 123 | 1.699951 | 100 | 48 | 38.5 | 191.8125 | 3.099609 | 9 | 2.299805 | 143 | 7.40918 | null | null | null | null | null | <2 mo. follow-up | 2.395508 |
240 | 88.69495 | 1 | male | 1 | 9 | 9 | Coma | Coma | 2 | null | >$50k | 89 | 24,242 | 14,263.6172 | null | 16 | white | 25.097656 | 41 | 0.056999 | 0.029999 | 1 | 0 | 0 | no | null | null | dnr after sadm | 3 | 102 | 11.599609 | 123 | 14 | 38.39844 | 397.125 | 3.099609 | 0.699951 | 5.699219 | 135 | 7.40918 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
241 | 68.01898 | 1 | male | 0 | 81 | 277 | MOSF w/Malig | ARF/MOSF | 1 | null | null | 26 | 659,433 | 324,373.75 | null | 42.25 | white | 32.398438 | 58 | 0.143982 | 0.067993 | 30 | 0 | 0 | metastatic | null | null | no dnr | 81 | 70 | 12.599609 | 115 | 10 | 37.5 | 218 | 2.599609 | 7.699219 | 2.799805 | 134 | 7.479492 | null | null | null | null | null | null | 3.217285 |
242 | 81.77698 | 1 | female | 0 | 7 | 927 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 7 | null | 0 | 5,405 | 3,686.4316 | null | 5 | black | 16.898438 | 32 | 0.703979 | 0.541992 | 1 | 0 | 0 | no | null | 0.8 | no dnr | 7 | 107 | 3.599609 | 92 | 26 | 36.79688 | null | 2.199707 | null | 0.699951 | 138 | null | null | null | null | 5 | 0 | SIP>=30 | 0 |
243 | 71.86298 | 1 | male | 0 | 3 | 12 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | under $11k | 0 | 3,869 | 2,602.3711 | null | 6 | white | 16.398438 | 25 | 0.878906 | 0.79895 | 1 | 1 | 0 | no | null | null | no dnr | 3 | 87 | 8.099609 | 80 | 20 | 36.09375 | 342.8125 | null | null | 1.5 | 138 | 7.439453 | null | null | null | null | null | <2 mo. follow-up | 2.296387 |
244 | 72.19696 | 0 | female | 0 | 8 | 1,849 | CHF | COPD/CHF/Cirrhosis | 3 | null | null | 9 | 9,991 | 6,090.7852 | null | 7 | black | 18.296875 | 34 | 0.841919 | 0.73999 | 1 | 1 | 0 | no | null | null | no dnr | 8 | 107 | 6.699219 | 72 | 18 | 36.79688 | null | null | null | 2.299805 | 141 | null | null | null | null | null | null | null | 3.44043 |
245 | 53.40997 | 0 | male | 0 | 12 | 1,847 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 14 | null | 26 | 102,911 | 52,412.25 | null | 24 | white | 27.199219 | 35 | 0.653931 | 0.554932 | 9 | 0 | 0 | no | 0.95 | 0.9 | no dnr | 12 | 113 | 25.5 | 120 | 25 | 37.29688 | 260 | 2.5 | 5.799805 | 0.799927 | 136 | 7.489258 | null | null | null | null | null | no(M2 and SIP pres) | 2.511231 |
246 | 34.35699 | 1 | male | 1 | 8 | 8 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 10 | null | 26 | 110,596 | 55,677.625 | null | 51 | hispanic | 44.398438 | 72 | 0.305969 | 0.192993 | 9 | 0 | 0 | no | 0.2 | 0.008 | no dnr | 8 | 48 | 6.199219 | 120 | 33 | 38.5 | 150 | 2.399902 | 6 | 2.299805 | 130 | 7.30957 | null | null | null | null | 5 | <2 mo. follow-up | 5 |
247 | 56.66498 | 1 | male | 1 | 14 | 14 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 0 | 206,651 | 102,511.375 | null | 47.666657 | white | 41.898438 | 81 | 0.324951 | 0.209991 | 31 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 10 | 63 | 18.597656 | 125 | 30 | 38.5 | 148 | null | 16.796875 | 4.099609 | 147 | 7.189453 | null | null | null | null | null | <2 mo. follow-up | 2.322754 |
248 | 53.67798 | 1 | female | 0 | 11 | 308 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 13 | null | 0 | 14,583 | 8,907.6328 | null | 9.5 | white | 24.796875 | 43 | 0.751953 | 0.60791 | 1 | 0 | 0 | no | 0.5 | 0.25 | no dnr | 11 | 113 | 7.5 | 100 | 24 | 37 | null | 2 | 19.898438 | 1.299805 | 137 | null | null | null | null | 0 | 0 | null | 0 |
249 | 55.32898 | 0 | male | 0 | 6 | 1,845 | Lung Cancer | Cancer | 2 | 12 | $25-$50k | 0 | 11,985 | 7,751.6758 | null | 12 | asian | 17.898438 | 11 | 0.712891 | 0.432983 | 1 | 0 | 0 | metastatic | null | null | no dnr | 6 | 93 | null | 112 | 20 | 37.19531 | null | null | null | 0.899902 | 136 | null | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
250 | 54.056 | 1 | male | 1 | 8 | 8 | Coma | Coma | 2 | 18 | $25-$50k | 55 | 46,156 | 22,832.2656 | null | 31 | white | 30.898438 | 53 | 0.345947 | 0.272949 | 1 | 0 | 0 | no | null | null | dnr after sadm | 8 | 110 | 29.597656 | 165 | 34 | 39.19531 | 223.3125 | null | 1.899902 | 1.699951 | 128 | 7.5 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
251 | 70.80396 | 1 | male | 1 | 19 | 19 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 10 | $11-$25k | 37 | 222,230 | 110,654.812 | null | 40.333313 | hispanic | 31.199219 | 60 | 0.366943 | 0.248993 | 14 | 1 | 0 | no | null | null | dnr after sadm | 19 | 83 | 16.898438 | 135 | 34 | 39 | 296.25 | null | 12.099609 | 1.399902 | 134 | 7.5 | null | null | null | null | null | <2 mo. follow-up | 3.210938 |
252 | 86.57098 | 1 | female | 1 | 4 | 4 | Coma | Coma | 1 | null | null | 94 | 10,662 | 5,654.9883 | null | 14 | white | 30.398438 | 40 | 0.003 | 0.001 | 1 | 0 | 0 | yes | null | null | dnr after sadm | 1 | 97 | 15.099609 | 80 | 28 | 36.79688 | 24 | null | null | 1.199951 | 133 | 7.239258 | null | null | null | null | null | <2 mo. follow-up | 3.831543 |
253 | 52.44897 | 1 | male | 0 | 6 | 1,079 | Lung Cancer | Cancer | 2 | null | null | 0 | 10,469 | 6,520.1992 | null | 10 | white | 4.399414 | 16 | 0.895996 | 0.761963 | 1 | 1 | 0 | metastatic | null | null | no dnr | 6 | 84 | 11.5 | 80 | 20 | 36.19531 | null | 4.5 | 0.299988 | 1 | 136 | null | null | null | null | null | 0 | null | 0 |
254 | 50.97897 | 1 | male | 0 | 9 | 1,600 | COPD | COPD/CHF/Cirrhosis | 2 | 14 | under $11k | 0 | 27,015 | 12,740.8125 | null | 11.5 | white | 26.398438 | 29 | 0.830933 | 0.724976 | 5 | 0 | 0 | no | 0.98 | 0.95 | no dnr | 9 | 122 | 9.099609 | 110 | 32 | 36.5 | 124.48438 | null | null | 0.799927 | 137 | 7.419922 | null | null | null | 1 | 1 | no(M2 and SIP pres) | 1 |
255 | 77.75995 | 1 | male | 1 | 7 | 7 | CHF | COPD/CHF/Cirrhosis | 2 | 14 | null | 0 | 34,038 | 18,083.2969 | null | 27 | white | 16 | 37 | 0.866943 | 0.778931 | 1 | 0 | 0 | no | null | null | no dnr | 7 | 58 | 4.899414 | 60 | 16 | 36.19531 | null | 4.299805 | null | 1.599854 | 133 | null | null | null | null | 0 | 0 | <2 mo. follow-up | 0 |
256 | 54.18198 | 1 | male | 1 | 6 | 6 | MOSF w/Malig | ARF/MOSF | 1 | 17 | >$50k | 9 | 40,620 | 20,159.0312 | null | 46 | white | 36 | 64 | 0.330994 | 0.215973 | 2 | 0 | 0 | yes | 0 | 0 | dnr after sadm | 4 | 60 | 4.5 | 190 | 40 | 39.5 | 90 | 1.699951 | 0.5 | 1.199951 | 130 | 7.30957 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
257 | 34.17398 | 1 | female | 1 | 5 | 5 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 13 | under $11k | 26 | 39,002 | null | null | 56 | white | 49.296875 | 53 | 0.21698 | 0.119995 | 3 | 0 | 0 | no | 0.1 | 0.001 | dnr after sadm | 4 | 67 | 1.599854 | 85 | 34 | 33.89844 | 46 | null | 1.899902 | 0.299988 | 128 | 7.399414 | null | null | null | null | 3 | <2 mo. follow-up | 3 |
258 | 80.52295 | 1 | male | 0 | 5 | 164 | CHF | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 5,853 | 3,727.5195 | null | 8 | white | 17.5 | 35 | 0.842896 | 0.74292 | 1 | 1 | 0 | no | null | null | no dnr | 5 | 97 | 7.199219 | 88 | 20 | 36.79688 | 319 | 4 | 0.699951 | 3.199707 | 136 | 7.489258 | null | null | null | null | null | null | 2.661133 |
259 | 50.53 | 1 | male | 0 | 6 | 1,349 | CHF | COPD/CHF/Cirrhosis | 2 | 13 | null | 0 | 18,574 | 11,205.3984 | null | 16 | null | 15.5 | 18 | 0.917969 | 0.861938 | 3 | 0 | 0 | no | null | null | no dnr | 6 | 66 | 4.899414 | 80 | 24 | 36.69531 | null | null | null | 1.399902 | 134 | null | null | null | null | null | null | null | 2.05957 |
260 | 56.82397 | 1 | female | 0 | 15 | 699 | COPD | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 49,730 | 23,862.5781 | null | 13 | black | 20.898438 | 15 | 0.849976 | 0.75293 | 2 | 0 | 0 | yes | 0.7 | 0.65 | no dnr | 15 | 70 | 22 | 60 | 19 | 37 | 165.6875 | null | null | 1 | 137 | 7.449219 | null | null | null | null | null | adl>=4 (>=5 if sur) | 3.105957 |
261 | 45.892 | 1 | male | 0 | 76 | 105 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 9 | 330,735 | null | null | 20.5 | black | 19.898438 | 34 | 0.835938 | 0.779907 | 54 | 0 | 0 | no | null | null | no dnr | 76 | 115 | 9.798828 | 145 | 32 | 38.69531 | 510 | 2 | 0.299988 | 0.899902 | 136 | 7.40918 | null | null | null | null | null | null | 2.686523 |
262 | 69.71698 | 1 | female | 1 | 4 | 4 | Coma | Coma | 2 | null | null | 100 | 21,696 | 11,611.6016 | null | 34 | white | 19.597656 | 25 | 0.283997 | 0.214996 | 1 | 1 | 0 | no | 0.1 | 0.001 | dnr after sadm | 3 | 115 | 14 | 95 | 16 | 36.39844 | 236.65625 | null | 0.399963 | 1.799805 | 141 | 7.469727 | null | null | null | null | null | <2 mo. follow-up | 2.983887 |
263 | 65.89996 | 1 | male | 0 | 20 | 693 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 11 | $11-$25k | 26 | 143,419 | null | null | 25 | white | 19.5 | 50 | 0.734985 | 0.652954 | 18 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 20 | 130 | 6.699219 | 110 | 26 | 38.19531 | 365 | 2.099609 | 0.199982 | 1.199951 | 131 | 7.5 | null | null | null | 1 | null | null | 1.1669 |
264 | 38.491 | 0 | male | 0 | 21 | 1,821 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 111,543 | 56,904.375 | null | 22.333328 | white | 32 | 43 | 0.747925 | 0.667969 | 4 | 0 | 0 | no | 0.6 | 0.6 | no dnr | 21 | 123 | 12.898438 | 125 | 38 | 39.79688 | 162 | 2.899902 | 3.399902 | 0.699951 | 134 | 7.259766 | null | null | null | null | null | null | 2.45459 |
265 | 65.53595 | 1 | male | 0 | 14 | 1,332 | MOSF w/Malig | ARF/MOSF | 1 | 27 | >$50k | 0 | 61,126 | 30,566.9375 | null | 21.333328 | black | 20.597656 | 27 | 0.759888 | 0.68396 | 1 | 0 | 0 | yes | 0.5 | 0.5 | no dnr | 14 | 108 | 10.699219 | 100 | 12 | 39.29688 | 220 | 2.299805 | 0.899902 | 1.799805 | 136 | 7.40918 | null | null | null | null | null | no(M2 and SIP pres) | 2.101074 |
266 | 59.146 | 1 | male | 0 | 10 | 585 | Lung Cancer | Cancer | 2 | 11 | null | 0 | 17,737 | 9,855.5469 | null | 10.5 | white | 18.699219 | 23 | 0.68689 | 0.393982 | 1 | 0 | 0 | metastatic | 0.5 | 0.1 | no dnr | 10 | 74 | 2.699707 | 128 | 24 | 38.89844 | null | null | 1.199951 | 0.899902 | 138 | null | null | null | null | 3 | 3 | null | 3 |
267 | 53.922 | 1 | female | 0 | 24 | 78 | Colon Cancer | Cancer | 1 | 16 | $25-$50k | 0 | 46,135 | 28,130.0312 | null | 12.666664 | white | 4.599609 | 14 | 0.93689 | 0.849976 | 1 | 0 | 0 | metastatic | 0.9 | 0.5 | no dnr | 24 | 83 | 10.5 | 100 | 24 | 37.39844 | null | 4.599609 | 0.399963 | 0.799927 | 135 | null | null | null | null | null | null | null | 2.050293 |
268 | 40.63199 | 0 | male | 0 | 13 | 1,816 | CHF | COPD/CHF/Cirrhosis | 1 | 1 | $11-$25k | 0 | 29,551 | 16,497.9375 | null | 17 | hispanic | 19.398438 | 23 | 0.920898 | 0.865967 | 1 | 0 | 0 | no | 0.75 | 0.6 | no dnr | 13 | 95 | null | 94 | 26 | 36 | null | null | null | 1.5 | 140 | null | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
269 | 65.67596 | 1 | male | 0 | 25 | 62 | Lung Cancer | Cancer | 1 | null | null | 0 | 57,969 | 33,842.3438 | null | 10.25 | white | 33.695313 | 35 | 0.260986 | 0.035995 | 1 | 0 | 0 | metastatic | 0.8 | 0.3 | dnr after sadm | 12 | 64 | 11.398438 | 134 | 32 | 38.79688 | 309.5 | 2.599609 | null | 0.799927 | 132 | 7.519531 | null | null | null | 0 | null | null | 0.4948 |
270 | 53.10098 | 1 | male | 1 | 4 | 4 | CHF | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 15,394 | 7,895.8438 | null | 29 | white | 32.695313 | 35 | 0.725952 | 0.571899 | 1 | 0 | 0 | no | null | null | no dnr | 4 | 43 | 13.298828 | 150 | 22 | 36.69531 | 610 | 3.799805 | 1.5 | 1.299805 | 132 | 7.679688 | null | null | null | null | null | <2 mo. follow-up | 2.807129 |
271 | 43.28299 | 1 | female | 1 | 7 | 7 | MOSF w/Malig | ARF/MOSF | 1 | null | null | 100 | 100,051 | null | null | 21.5 | null | 33.898438 | 63 | 0.014 | 0.003 | 22 | 0 | 0 | yes | 0.5 | 0.3 | dnr after sadm | 3 | 87 | 0.299988 | 140 | 44 | 38.5 | 259.125 | 2.699707 | 3.199707 | 1.5 | 146 | 7.479492 | null | null | null | null | null | <2 mo. follow-up | 3.533203 |
272 | 35.14297 | 1 | male | 0 | 5 | 1,131 | Lung Cancer | Cancer | 0 | 14 | >$50k | 0 | 7,880 | 4,021.0273 | null | 10 | white | 16.796875 | 13 | 0.774902 | 0.530884 | 1 | 0 | 0 | metastatic | null | null | no dnr | 5 | 77 | 8.298828 | 80 | 18 | 35.39844 | null | null | null | 0.899902 | 137 | null | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
273 | 51.49899 | 1 | female | 0 | 4 | 28 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 12 | under $11k | 0 | 5,765 | 3,633.0703 | null | 9 | white | 18 | 27 | 0.820923 | 0.708984 | 1 | 0 | 0 | yes | null | null | no dnr | 4 | 87 | 6.099609 | 88 | 20 | 36.59375 | 366.625 | 2.299805 | 2 | 1.199951 | 130 | 7.549805 | null | null | null | null | 3 | <2 mo. follow-up | 3 |
274 | 76.44897 | 1 | male | 0 | 18 | 19 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 11 | null | 26 | 92,307 | 49,963.5 | null | 23.666656 | white | 24.898438 | 37 | 0.593994 | 0.484985 | 6 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 18 | 108 | 14.798828 | 140 | 20 | 39 | null | null | null | 2 | 144 | null | null | null | null | null | 6 | <2 mo. follow-up | 6 |
275 | 81.24597 | 1 | female | 1 | 3 | 3 | Coma | Coma | 1 | null | null | 100 | 15,473 | 7,722.8047 | null | 43 | white | 24.097656 | 58 | 0.080994 | 0.046997 | 1 | 0 | 1 | no | 0.05 | 0.000125 | dnr before sadm | 0 | 58 | 8.5 | 70 | 30 | 37.5 | 178 | 2.5 | 1.5 | 2.299805 | 135 | 7.369141 | null | null | null | null | null | <2 mo. follow-up | 5.240234 |
276 | 19.60599 | 1 | female | 1 | 5 | 5 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 0 | 413,774 | null | null | 48 | white | 42.296875 | 59 | 0.56189 | 0.449951 | 40 | 0 | 0 | no | 0 | 0 | dnr after sadm | 5 | 48 | 6.099609 | 131 | 12 | 38.79688 | 156.25 | 4.399414 | 16.398438 | 1.099854 | 155 | 7.519531 | null | null | null | null | null | <2 mo. follow-up | 2.126465 |
277 | 63.431 | 0 | male | 0 | 61 | 1,809 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 16 | $11-$25k | 26 | 409,250 | null | null | 34.5 | white | 31.296875 | 34 | 0.472961 | 0.353943 | 15 | 0 | 0 | no | null | 0.6 | no dnr | 61 | 90 | 3.399902 | 130 | 20 | 37.09375 | 230 | 2.799805 | 4.699219 | 2.099609 | 141 | 7.489258 | null | null | null | null | 2 | no(M2 and SIP pres) | 2 |
278 | 52.37198 | 1 | male | 0 | 5 | 644 | COPD | COPD/CHF/Cirrhosis | 3 | 12 | under $11k | 0 | 6,622 | 3,758.2363 | null | 11 | black | 14.898438 | 10 | 0.939941 | 0.897949 | 1 | 0 | 0 | no | 1 | 1 | no dnr | 5 | 102 | 15.5 | 80 | 18 | 37 | 300 | null | null | 1 | 140 | 7.429688 | null | null | null | 1 | null | no(M2 and SIP pres) | 1.1669 |
279 | 38.883 | 0 | male | 0 | 15 | 1,807 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 16 | null | 37 | 34,680 | 18,825.9219 | null | 18.666656 | hispanic | 20 | 21 | 0.852905 | 0.802979 | 1 | 0 | 0 | no | 0.6 | 0.5 | no dnr | 15 | 83 | 7 | 110 | 30 | 38.69531 | 257.125 | 3.599609 | 0.099991 | 0.699951 | 133 | 7.449219 | null | null | null | null | 6 | adl>=4 (>=5 if sur) | 6 |
280 | 77.67596 | 1 | male | 1 | 4 | 4 | MOSF w/Malig | ARF/MOSF | 1 | null | null | 41 | 26,620 | 13,928.5234 | null | 39 | white | 40.898438 | 73 | 0.015999 | 0.003 | 4 | 0 | 0 | metastatic | null | null | dnr after sadm | 2 | 38 | 10.099609 | 110 | 20 | 38.79688 | 207.6875 | null | 2.799805 | 2.099609 | 131 | 7.279297 | null | null | null | null | null | <2 mo. follow-up | 3.762695 |
281 | 75.96698 | 1 | female | 0 | 9 | 34 | Lung Cancer | Cancer | 2 | 12 | under $11k | 9 | 12,424 | 7,979.4453 | null | 7.5 | white | 16.796875 | 30 | 0.650879 | 0.344971 | 1 | 0 | 0 | metastatic | null | null | dnr after sadm | 5 | 107 | 25.5 | 100 | 20 | 36.39844 | null | 3.899902 | null | 1.5 | 135 | null | null | null | null | null | 0 | <2 mo. follow-up | 0 |
282 | 42.38699 | 1 | female | 1 | 12 | 12 | MOSF w/Malig | ARF/MOSF | 1 | null | null | 0 | 221,026 | 108,952.438 | null | 35 | white | 40.09375 | 56 | 0.186981 | 0.097992 | 24 | 0 | 0 | yes | null | null | dnr after sadm | 2 | 112 | 1.399902 | 70 | 18 | 36.59375 | 144 | 4.599609 | 7.5 | 3.899902 | 143 | 7.459961 | null | null | null | null | null | <2 mo. follow-up | 2.336914 |
283 | 47.24698 | 1 | female | 0 | 10 | 108 | Lung Cancer | Cancer | 1 | 16 | null | 0 | 29,076 | 15,755.8828 | null | 27 | asian | 40.695313 | 44 | 0.136993 | 0.007 | 1 | 0 | 0 | metastatic | 0.9 | 0.5 | no dnr | 10 | 47 | 12.798828 | 140 | 32 | 38.59375 | 246.9375 | 2.599609 | 1.299805 | 1.299805 | 135 | 7.369141 | null | null | null | null | null | null | 2.960449 |
284 | 69.66699 | 1 | male | 1 | 14 | 14 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | null | null | 0 | 122,908 | 62,152.9062 | null | 44.333313 | white | 29.796875 | 38 | 0.452942 | 0.251953 | 3 | 0 | 0 | no | null | null | dnr after sadm | 13 | 93 | 12.298828 | 150 | 14 | 37 | 142.84375 | 2.399902 | 5.399414 | 0.899902 | 138 | 7.279297 | null | null | null | null | null | <2 mo. follow-up | 2.55127 |
285 | 57.58197 | 1 | male | 0 | 10 | 1,395 | CHF | COPD/CHF/Cirrhosis | 3 | 10 | under $11k | 0 | 26,110 | 15,292.6016 | null | 17.5 | white | 20 | 38 | 0.880981 | 0.80188 | 1 | 0 | 0 | no | 0.85 | 0.75 | no dnr | 10 | 65 | 5 | 125 | 26 | 36.89844 | 400 | 3.899902 | 2.799805 | 1.299805 | 140 | 7.539062 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
286 | 50.64798 | 0 | male | 0 | 10 | 1,798 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 23,376 | 13,861.8125 | null | 21.5 | black | 18.5 | 28 | 0.908936 | 0.845947 | 1 | 0 | 0 | no | 0.8 | 0.5 | no dnr | 10 | 67 | 5.299805 | 115 | 30 | 36.79688 | 419 | 3.399902 | 1.399902 | 1.199951 | 143 | 7.439453 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
287 | 60.07898 | 1 | male | 0 | 11 | 800 | Colon Cancer | Cancer | 1 | 12 | >$50k | 0 | 22,300 | 13,441.8594 | null | 11.5 | white | 7.899414 | 18 | 0.911987 | 0.796997 | 1 | 0 | 0 | metastatic | 0.95 | 0.75 | no dnr | 11 | 103 | 4.299805 | 110 | 18 | 36.79688 | 283.3125 | 4.299805 | 0.299988 | 1.099854 | 142 | 7.379883 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
288 | 67.47998 | 1 | male | 0 | 11 | 406 | Colon Cancer | Cancer | 1 | null | null | 0 | 11,506 | 7,928.3516 | null | 11 | white | 9 | 24 | 0.896973 | 0.763916 | 1 | 0 | 0 | metastatic | 0.99 | 0.75 | no dnr | 11 | 108 | 6.5 | 58 | 20 | 38.89844 | null | 4.099609 | 0.299988 | 1.5 | 143 | null | null | null | null | null | null | null | 2.262695 |
289 | 62.875 | 1 | male | 0 | 9 | 1,126 | Colon Cancer | Cancer | 1 | 14 | >$50k | 0 | 23,575 | 14,252.5938 | null | 8 | white | 7.199219 | 20 | 0.914917 | 0.80188 | 1 | 0 | 0 | metastatic | 0.95 | 0.75 | no dnr | 9 | 96 | 12.5 | 120 | 24 | 39 | null | 4.599609 | 0.199982 | 0.799927 | 137 | null | null | null | null | 2 | null | no(M2 and SIP pres) | 1.839 |
290 | 74.10797 | 1 | male | 1 | 17 | 17 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | $11-$25k | 44 | 73,695 | 34,402.0938 | null | 26.333328 | white | 28.898438 | 35 | 0.462952 | 0.260986 | 1 | 0 | 1 | no | 0.5 | 0.4 | dnr after sadm | 5 | 63 | 22 | 160 | 12 | 37 | 134 | null | null | 0.599976 | 140 | 7.429688 | null | null | null | null | 7 | <2 mo. follow-up | 7 |
291 | 66.73199 | 1 | male | 0 | 18 | 576 | Colon Cancer | Cancer | 2 | 16 | $25-$50k | 0 | 30,052 | 18,453.2812 | null | 11.666664 | white | 10.599609 | 21 | 0.884888 | 0.737915 | 1 | 0 | 0 | metastatic | 0.7 | 0.5 | no dnr | 18 | 110 | 9.199219 | 90 | 28 | 37.19531 | null | 3.899902 | 0.5 | 0.899902 | 140 | null | null | null | null | 1 | null | no(M2 and SIP pres) | 1.1669 |
292 | 71.39996 | 1 | female | 0 | 40 | 42 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 16 | $25-$50k | 0 | 163,714 | 85,802.9375 | null | 20.25 | white | 26.699219 | 29 | 0.690918 | 0.598999 | 5 | 1 | 0 | no | null | null | dnr after sadm | 32 | 120 | 10.798828 | 65 | 22 | 36.59375 | 86.65625 | null | 0.5 | 1.599854 | 143 | 7.469727 | null | null | null | 5 | null | <2 mo. follow-up | 3.855299 |
293 | 60.85699 | 1 | female | 0 | 9 | 309 | Lung Cancer | Cancer | 0 | null | null | 0 | 22,052 | 13,990.0859 | null | 11 | white | 10.099609 | 29 | 0.826904 | 0.625 | 1 | 0 | 0 | metastatic | null | null | no dnr | 9 | 98 | 3.799805 | 110 | 20 | 37.5 | 196 | 4.199219 | 0.099991 | 1.099854 | 136 | 7.40918 | null | null | null | null | null | null | 2.550781 |
294 | 47.37598 | 1 | female | 1 | 19 | 19 | MOSF w/Malig | ARF/MOSF | 1 | 12 | $11-$25k | 26 | 266,998 | 128,401.812 | null | 38.333313 | white | 32.398438 | 52 | 0.262939 | 0.156982 | 23 | 0 | 0 | yes | 0.8 | 0.8 | dnr after sadm | 19 | 78 | 7.599609 | 130 | 25 | 39.69531 | 152 | null | 1.199951 | 4.599609 | 145 | 7.379883 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
295 | 71.15094 | 1 | female | 1 | 13 | 13 | CHF | COPD/CHF/Cirrhosis | 5 | 10 | $11-$25k | 0 | 27,021 | 15,741.9766 | null | 22.5 | black | 23.398438 | 40 | 0.797974 | 0.674927 | 1 | 1 | 0 | no | null | null | dnr after sadm | 10 | 127 | 6.699219 | 110 | 24 | 37.5 | 455.5 | null | 1 | 3.5 | 140 | 7.40918 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
296 | 64.24597 | 0 | female | 0 | 15 | 1,788 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | under $11k | 0 | 32,157 | 17,095.1094 | null | 12.666664 | hispanic | 25.796875 | 47 | 0.768921 | 0.694946 | 2 | 0 | 0 | no | 0.95 | 0.95 | no dnr | 15 | 77 | 33.59375 | 110 | 22 | 38 | 346.625 | null | 1.599854 | 3 | 143 | 7.269531 | null | null | null | null | 1 | null | 1 |
297 | 21.63699 | 1 | female | 0 | 10 | 591 | Colon Cancer | Cancer | 1 | 16 | >$50k | 0 | 17,730 | 11,209.3672 | null | 9.5 | white | 19.398438 | 15 | 0.858887 | 0.685913 | 1 | 0 | 0 | metastatic | 0.95 | 0.9 | no dnr | 10 | 88 | 17.097656 | 74 | 20 | 36.39844 | null | null | 4.199219 | 0.899902 | 138 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
298 | 60.58899 | 1 | male | 1 | 7 | 7 | Lung Cancer | Cancer | 2 | 12 | >$50k | 9 | 17,989 | 10,208.0312 | null | 11.5 | white | 23.097656 | 26 | 0.539917 | 0.21698 | 1 | 0 | 0 | metastatic | null | null | dnr after sadm | 6 | 117 | 12.398438 | 135 | 26 | 36.5 | null | null | 0.299988 | 1.099854 | 133 | null | null | null | null | null | 0 | <2 mo. follow-up | 0 |
299 | 55.20599 | 1 | female | 0 | 13 | 829 | COPD | COPD/CHF/Cirrhosis | 1 | null | null | 0 | 28,330 | 15,057.5703 | null | 12.5 | black | 17.398438 | 19 | 0.918945 | 0.863892 | 1 | 0 | 0 | no | 0.6 | 0.4 | no dnr | 13 | 93 | 5.799805 | 95 | 26 | 37.29688 | 223.3125 | null | null | 0.699951 | 142 | 7.379883 | null | null | null | 6 | 6 | adl>=4 (>=5 if sur) | 6 |
300 | 66.54596 | 1 | male | 1 | 45 | 45 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 15 | >$50k | 0 | 348,628 | 177,669.875 | null | 37.75 | white | 31.199219 | 38 | 0.565918 | 0.453979 | 27 | 0 | 0 | no | 0.95 | 0.95 | dnr after sadm | 45 | 67 | 19.699219 | 150 | 20 | 39.39844 | 182.5 | 3.799805 | 1.699951 | 1.5 | 127 | 7.469727 | null | null | null | null | null | <2 mo. follow-up | 2.989746 |